ArticleJournal of virology2006

R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.

Françoise Gondois-Rey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.